A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease - Eich, Andreas; Urban, Veronika; Jutel, Marek; Vlcek, Jiri; Shim, Jae Jeong; Trofimov, Vasiliy I.; Liam, Chong-Kin; Kuo, Ping-Hung; Hou, Yanyan; Xiao, Jun; Branigan, Patrick; O'Brien, Christopher D. (Chronic obstructive pulmonary disease, 2017)
Keywords: Antibodies; forced expiratory volume; interleukin-17; monoclonal; safety; Antibodies; forced expiratory volume; interleukin-17; monoclonal; safety